当前位置: 首页 > 学术动态

学术报告:Bioengineering of Direct Cellular Reprogramming

发布者: 发布时间:2014-11-26 游览次数:


题 目:Bioengineering of Direct Cellular Reprogramming

报告人:Kam W Leong 教授 Columbia University

时 间:12月8日上午9:00

地 点:启秀校区C4报告厅


                神经再生重点实验室
                  2014-11-26

 

Kam W Leong 教授简介

    Kam W. Leong is the Samuel Y. Sheng Professor of Biomedical Engineering at Columbia University. His lab works on nanoparticle-mediated nonviral gene delivery and immunotherapy, from design and synthesis of new carriers to applications for hemophilia and infectious diseases. The lab also works on the application of nanostructured biomaterials for regenerative medicine, particularly on understanding cell-topography interactions and on the application of nonviral vectors for direct cellular reprogramming. He has published -280 peer-reviewed research manuscripts and holds more than 50 issued patents, with an H-index of 80 and over 24,300 citations. His work has been recognized by a Young Investigator Research Achievement Award of the Controlled Release Society, Distinguished Scientist Award of the International Journal of Nanomedicine, and Clemson Award for Applied Research of the Society for Biomaterials. He is the Editor-in-Chief of Biomaterials, a member of the National Academy of Inventors, and a member of the USA National Academy of Engineering.